SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-061074
Filing Date
2024-05-16
Accepted
2024-05-16 16:05:36
Documents
2
Period of Report
2024-05-14

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1525
2 EX-24 syre-ex24.htm EX-24 7404
  Complete submission text file 0000950170-24-061074.txt   10481
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Milligan Sandra (Reporting) CIK: 0001859810 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37722 | Film No.: 24955500